Crossmark

Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes

Published Online: 2023-07-26

Published Print: 2023-10

Authors

Xie, Dengpiao

Wang, Qiqi

Huang, Wei

Zhao, Liangbin
License Information

Text and Data Mining valid from 2023-07-26

Version of Record valid from 2023-07-26
More Information

Article History

Received: 5 May 2023

Accepted: 16 July 2023

First Online: 26 July 2023

Declarations

:

: The authors declare no competing interests.

Document is current